David Ricks
David Ricks is the Chief Executive Officer of Eli Lilly and Company, a leading pharmaceutical company known for its innovations in diabetes and weight loss medications, including Zepbound and Mounjaro. Under his leadership, the company announced a significant $27 billion investment to expand its manufacturing capabilities in the United States, aiming to bolster domestic production in response to potential tariffs and supply chain vulnerabilities exposed during the COVID-19 pandemic. Ricks has emphasized the importance of reshoring production and increasing manufacturing capacity to meet the growing demand for Eli Lilly's products.
Not in the pool (under ¢1).
Recent news mentions
David Ricks, CEO of Eli Lilly, is noted for successfully negotiating with Trump for lower drug prices.
CEO auf dem Schleudersitz: KI-Tool berechnet Reputationsrisiken
Switzerland· 2026-01-25
David Ricks is the CEO of Eli Lilly who was speaking when Gordon Findlay fainted.
L'executiu d'una farmacèutica es desmaia al Despatx Oval durant un acte amb Trump
Andorra· 2025-11-08
David Ricks was speaking about a drug agreement when Gordon Findlay collapsed.
Incident în timpul unei conferințe în Biroul Oval: un bărbat s-a prăbușit lângă Donald Trump. Reacția președintelui SUA
Romania· 2025-11-07
David Ricks was speaking when the incident occurred at the White House.
Beyaz Saray'da panik: İlk müdahaleyi Dr. Mehmet Öz yaptı
Turkey· 2025-11-07
David Ricks is the CEO of Eli Lilly who was speaking about a weight loss drug deal when the incident occurred.
Mann kollabiert bei Trump-Pressekonferenz im Oval Office
Luxembourg· 2025-11-07
David Ricks, Eli Lilly's chief executive, said in a statement that Lilly is in a unique position to work with the US government to rebalance the global system.
Trump unveils deals to lower US weight-loss drug prices
United Kingdom· 2025-11-06
David Ricks believes that Giannis Skarimpas would appeal to English-speaking audiences who appreciate Beckett's prose.
Ο αιρετικός νεωτεριστής Γιάννης Σκαρίμπας
Greece· 2025-05-28
Eli Lilly, led by David Ricks, is putting $27 billion into expanding domestic pharmaceutical production.
Trump touts trillion-dollar surge in U.S. investment — here’s who’s cashing in
United States· 2025-05-01
David Ricks is Eli Lilly’s chief executive who commented on the potential of the new weight-loss pill.
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight – The Irish Times
Ireland· 2025-04-18
David Ricks, Eli Lilly’s chief executive, stated that orforglipron may provide a new option for weight management.
New daily weight-loss pill shows success at clinical trial – The Irish TimesIreland· 2025-04-18
David Ricks, Eli Lilly’s chief executive, discussed the potential of orforglipron as a new option for weight management.
New daily weight-loss pill shows success at clinical trial | ObesityUnited Kingdom· 2025-04-17David Ricks, the CEO of Eli Lilly, stated that orforglipron could provide a new opportunity for people worldwide if approved.
Novo-rivals vægttabspille består studie som den første af sin slags
Denmark· 2025-04-17David Ricks, the CEO of Eli Lilly, referred to the new drug as a 'convenient solution, with one pill daily.'
Ερχεται ο αντίπαλος του Ozempic – Νέο χάπι κατά της παχυσαρκίαςGreece· 2025-04-17David Ricks, CEO of Eli Lilly, announced plans to invest $27 billion to build four manufacturing plants in the US.
Trump drug tariffs would drive up prices, worsen shortages before any boost to US manufacturing, experts warnUnited States· 2025-04-09
David Ricks, CEO of Eli Lilly, expressed serious concerns about the impact of new tariffs on American businesses.
Thành trì ủng hộ ông Trump xuất hiện vết nứt vì đòn thuế
Vietnam· 2025-04-08
David Ricks, the boss of US pharmaceutical giant Eli Lilly, described the tariffs imposed by Donald Trump as a watershed moment in US economic history.
US pharma boss calls tariffs a ‘pivotal moment'United Kingdom· 2025-04-04
David Ricks is Eli Lilly’s chief executive officer who discussed the company's investment plans.
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffsUnited States· 2025-02-26